(Press-News.org) Contact: Michael Bernstein
m_bernstein@acs.org
504-670-4707 (New Orleans Press Center, April 5-10)
202-872-6042
Michael Woods
m_woods@acs.org
504-670-4707 (New Orleans Press Center, April 5-10)
202-872-6293
American Chemical Society
New evidence that natural substances in green coffee beans help control blood sugar levels
NEW ORLEANS, April 9, 2013 -- Scientists today described evidence that natural substances extracted from unroasted coffee beans can help control the elevated blood sugar levels and body weight that underpin type 2 diabetes. Their presentation on chlorogenic acids -- widely available as a dietary supplement -- was part of the 245th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society, being held here this week.
Joe Vinson, Ph.D., who led the research, pointed out that type 2 diabetes, the most common form of diabetes, is an increasing global health problem. In the United States alone, almost 26 million have the disease, in which the pancreas does not produce enough of the insulin that enables the body to use sugar, or cells resist the effects of that insulin. Blood sugar levels rise, increasing the risk of heart attacks, stroke and other health problems. Current treatments focus on oral medications that stimulate insulin secretions and/or reduce insulin resistance, dietary changes that control blood sugar levels and weight loss that reduces insulin resistance.
"A simple natural pill or capsule that would both help control blood sugar and foster weight loss at the same time would be a major advance in the treatment of type 2 diabetes," Vinson said. "Our own research and studies published by other scientists suggest that such a treatment may, indeed, exist. There is significant epidemiological and other evidence that coffee consumption reduces the risk of type 2 diabetes.
"One large study indicated a 50 percent risk reduction for people who drank seven cups of coffee a day compared to those who drank only two cups a day. I am trying to make the coffee and diabetes story as clear as possible for the public. The evidence points to chlorogenic acids as the active ingredients in coffee that both prevent diabetes and improve glucose control in normal, pre-diabetic and diabetic people."
Chlorogenic acids are a family of substances that occur naturally in apples, cherries, plums, dried plums and other fruits and vegetables. Vinson, who is with the University of Scranton in Pennsylvania, which funded the research, pointed out that coffee ― due to its popularity as a beverage ― is a major dietary source of these substances. Large amounts of chlorogenic acids exist in green, or unroasted, coffee beans. However, the high temperatures used to roast coffee beans to make them suitable for use in coffee breaks down much of the chlorogenic acids. Thus, the focus has been on using concentrated extracts of green coffee beans, which contain higher amounts of chlorogenic acids.
In a previous study, Vinson found that overweight or obese people who took such an extract lost about 10 percent of their body weight in 22 weeks. The new study sought to document the effects of various doses of a commercial green coffee extract on the blood sugar levels of 56 men and women with normal blood sugar levels. They got a glucose tolerance test to see how their bodies responded to the sugar. Then over a period of time, they took 100, 200, 300 or 400 milligrams (mg) of the extract in a capsule with water. Follow-up glucose tolerance tests showed how the green coffee extract affected their responses.
"There was a significant dose-response effect of the green coffee extract and no apparent gastrointestinal side effects," Vinson said. "All doses of green coffee extract produced a significant reduction in blood sugar relative to the original blank glucose challenge. The maximum blood glucose occurred at 30 minutes and was 24 percent lower than the original with the 400 mg of green coffee extract and the blood glucose at 120 minutes was 31 percent lower."
###
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 163,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter | Facebook
Note to journalists: Please report that this research was presented at a meeting of the American Chemical Society.
Abstract
There are now numerous epidemiological studies indicating that coffee consumption, especially decaffeinated coffee, will reduce the risk of all-cause mortality, heart failure and type 2 diabetes and Parkinson's disease. The studies' results are usually J-curves indicating an optimal consumption of 2-4 cups/day. The question then arises, what is/are the bioactive substance(s) in coffee -- Our study of antioxidants in foods and beverages indicated the coffee is the #1 source of polyphenol antioxidants in the US diet and this has been borne out in several European countries. Recent studies indicate that coffee consumption acutely increases human plasma antioxidant capacity. Other investigators have found multiple evidence of chlorogenic acid metabolites and colonic bacterial degradation products in plasma and urine after drinking coffee and green coffee extract. A recent study in India with obese subjects showed a significant weight loss and body fat reduction after consuming capsules containing a green coffee extract which was high in chlorogenic acids. Roasting is known to greatly reduce the levels of these compounds in the beverage coffee. One mechanism for the weight loss is purported to be the inhibition of glucose-6-phosphatase which forces lipids to be used as energy to compensate for the decrease in glucose release from glycogenolysis in the liver. As evidence for coffee's diabetes and heart disease protection we will present a new human study demonstrating a dose-response green coffee extract inhibition of glucose absorption during a glucose tolerance test in normal subjects. Studies with rats and humans have shown that the caffeine in coffee contributes to hyperglycemia after glucose consumption. The green coffee extract which is very low in caffeine and should be studied with pre-diabetes and type 2 diabetic subjects as a means to improve their blood glucose control.
New evidence that natural substances in green coffee beans help control blood sugar levels
2013-04-09
ELSE PRESS RELEASES FROM THIS DATE:
Spring rains bring life to Midwest granaries but foster Gulf of Mexico 'Dead Zone'
2013-04-09
Michael Woods
m_woods@acs.org
504-670-4707 (New Orleans Press Center, April 5-10)
202-872-6293
American Chemical Society
Spring rains bring life to Midwest granaries but foster Gulf of Mexico 'Dead Zone'
NEW ORLEANS, April 9, 2013 — The most serious ongoing water pollution problem in the Gulf of Mexico originates not from oil rigs, as many people believe, but rainstorms and fields of corn and soybeans a thousand miles away in the Midwest. An expert on that problem — the infamous Gulf of Mexico "Dead Zone" — today called for greater awareness of the connections ...
'Chemistry of the Bar' symposium focuses on New Orleans' Hurricane Cocktail and more
2013-04-09
Michael Woods
m_woods@acs.org
504-670-4707 (New Orleans Press Center, April 5-10)
202-872-6293
American Chemical Society
'Chemistry of the Bar' symposium focuses on New Orleans' Hurricane Cocktail and more
NEW ORLEANS, April 9, 2013 — Call their taste and effects appealing or appalling, no matter. In a city that claims credit for invention of the cocktail, the Hurricane, Sazerac, Pimm's Cup, Bayou Bash, Hand Grenade, Ramos Gin Fizz and other concoctions are the spirits of the French Quarter and its most famous thoroughfare, which happens to be named Bourbon ...
Fox Chase researchers show that a promising drug can help prevent head and neck cancers
2013-04-09
WASHINGTON, DC (April 9, 2013)—Head and neck cancers typically begin in squamous cells that line moist surfaces inside the mouth, nose and throat. Squamous cell carcinoma of the head and neck (HNSCC) is the sixth most common type of cancer in the United States, and it is sometimes preceded by the appearance of changes inside the oral cavity called precancerous lesions. The most common type of change is a white patch known as a leukoplakia. Because it often takes decades for leukoplakias to develop into HNSCC, there is a window of opportunity to recognize and revert precancerous ...
New treatment holds promise for resistant lung cancer
2013-04-09
WASHINGTON, DC (April 9, 2013)—A new chemotherapy regimen appears to produce minimal side effects in patients with lung cancer that has not responded to previous therapy, paving the way for additional research to determine if the new regimen also helps shrink tumors, according findings to be presented by Fox Chase Cancer Center researchers at the AACR Annual Meeting 2013 on Tuesday, April 9.
"I'm very optimistic that we will show this protocol helps lung cancer patients who have run out of other options," says study author Hossein Borghaei, MS, DO, director of Thoracic ...
Omega-3 fatty acids more effective at inhibiting growth of triple-negative breast cancer
2013-04-09
WASHINGTON, DC (April 9, 2013)—Researchers from Fox Chase Cancer Center have found that omega-3 fatty acids and their metabolite products slow or stop the proliferation, or growth in the number of cells, of triple-negative breast cancer cells more effectively than cells from luminal types of the disease. The omega-3s worked against all types of cancerous cells, but the effect was observed to be stronger in triple-negative cell lines, reducing proliferation by as much as 90 percent. The findings will be presented at the AACR Annual Meeting 2013 on Tuesday, April 9.
Omega-3 ...
Removal of hypothalamic hamartoma curbs compulsive eating and excessive weight gain
2013-04-09
Charlottesville, VA (April 9, 2013). Neurosurgeons at the University of Texas–Houston and Children's Memorial Hermann Hospital (Houston, Texas) report on the success they achieved when they removed a hypothalamic hamartoma (HH) from a 10-year-old girl to combat hyperphagia (excessive appetite and compulsive overeating) and consequent unhealthy weight gain. To the best of the authors' knowledge, this is the first time resection of an HH was performed for this particular reason. Findings in this case are reported and discussed in "Successful treatment of hyperphagia by resection ...
Mayo researchers identify gene variations that predict chemotherapy side effects
2013-04-09
ROCHESTER, Minn. -- Seemingly benign differences in genetic code from one person to the next could influence who develops side effects to chemotherapy, a Mayo Clinic study has found. The study identified gene variations that can predispose people to chemotherapy-induced peripheral neuropathy, a condition that is hard to predict and often debilitating enough to cause cancer patients to stop their treatment early. Results of the research were presented today at the American Association for Cancer Research Annual Meeting 2013 in Washington, D.C.
The study, which implicates ...
Ranibizumab may prevent retinal detachment side effect
2013-04-09
BOSTON (April 9, 2013) – Proliferative vitreoretinopathy (PVR), or the formation of scar tissue in the eye, is a serious, sight-threatening complication in people recovering from surgical repair of retinal detachment. PVR is difficult to predict, lacks effective treatment options, and substantially reduces an individual's quality of life. Each year 55,000 people are at risk for developing PVR in the United States alone.
A new study carried out by scientists from The Schepens Eye Research Institute/Massachusetts Eye and Ear and the Department of Ophthalmology, Harvard ...
AACR news: Misregulated genes common to tobacco-related cancers offer potential new prognostic tool
2013-04-09
Believe it or not, while researchers have explored which genes are mutated in each type of tobacco-associated cancer, until now no one had thought to look across these types for common genes that might predict patient outcomes. Results presented at the AACR Annual Meeting 2013 show that in lung and bladder cancers, genes related to the regulation of the cell cycle are associated with poor patient outcomes.
"We ultimately envision this as a prognostic tool to predict survival rates for people with tobacco related cancers. Recognizing patients with high expression of these ...
AACR news: K9 osteosarcoma samples identify drivers of metastasis in pediatric bone cancer
2013-04-09
Human osteosarcoma samples are hard to come by, making the disease difficult to study. However, K9 bone cancer is genetically indistinguishable from the human form of the disease, and over 10,000 canine patients develop the disease every year. Research from the University of Colorado Cancer Center and the Colorado State University Flint Animal Cancer Center presented at the AACR Annual Meeting 2013 used easily available K9 osteosarcoma samples to discover a novel protein that governs metastasis and chemoresistance in pediatric osteosarcoma.
"We have a pediatric osteosarcoma ...